Status:
COMPLETED
Symptom Tracking in Long COVID Patients Using Formula C™ Sublingual Drops
Lead Sponsor:
Endourage, LLC
Conditions:
Long COVID
Long Covid19
Eligibility:
All Genders
21+ years
Brief Summary
This is a digital symptom tracking study of Formula C™, a full cannabis flower formulation, rich in cannabinoids and terpenes, that has been shown to improve symptoms in people with Long COVID. Partic...
Detailed Description
Long COVID is a global health crisis with no current treatments. There's a growing interest within the medical community to explore the potential benefits of full hemp flower extracts in treating and ...
Eligibility Criteria
Inclusion
- Must be at least 21 years of age.
- Willing and able to read, understand, and sign the informed consent.
- Willing to comply with all study procedures.
- Must have device to access the internet to complete surveys online.
- A diagnosis of Long COVID from a health care provider.
Exclusion
- Non-English speaking, as the surveys are developed in the English language.
- Known allergies to hemp seeds or hemp-derived products, medical cannabis, coconut oil.
- Pregnancy, or planning to become pregnant in the next 3 months
Key Trial Info
Start Date :
December 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06163690
Start Date
December 13 2023
End Date
January 31 2025
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endourage, LLC
Denver, Colorado, United States, 80033